More about Narayana Hrudayalaya Limited
Fundamentals for Narayana Hrudayalaya Limited
Regulatory Filings for Narayana Hrudayalaya Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Narayana Hrudayalaya Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Revenue projections:
NH's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.
Financial Ratios:
| currentRatio | 2.146000 |
|---|---|
| forwardPE | 29.462645 |
| debtToEquity | 57.614000 |
| earningsGrowth | 0.301000 |
| revenueGrowth | 0.174000 |
| grossMargins | 0.410410 |
| operatingMargins | 0.191650 |
| trailingEps | 41.570000 |
| forwardEps | 59.285240 |
The current ratio for NH is 2.146, indicating that the company can service its short-term debt using available cash and assets. This suggests NH has strong liquidity, with more than enough resources to meet its immediate financial commitments.
NH's Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
With positive growth in both earnings and revenue, NH is expected to grow its business. These indicators highlight a strong financial outlook, with the company on track for continued expansion and increasing profitability.
NH's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with NH anticipated to deliver better earnings than it did in the prior year.
Price projections:
The price of NH has often been situated close to the lower end of projections. This consistent trend may signal difficulties for the company in achieving investor expectations for future performance.
Insider Transactions:
1 sell transactions of Narayana Hrudayalaya Limited were recorded, with market price hovering near 1957.300048828125.The period under consideration saw no sell transactions.The higher volume of buys compared to sells near current NH price levels may suggest optimism among investors. This could point to a favorable market outlook, as more people are willing to invest at these prices, anticipating potential future growth or strong performance.
Recommendation changes over time:
With analysts showing a buy bias for NH, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning NH as a safe and profitable place for investors to allocate their funds and seek growth.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction